v3 Template
A

Aligos Therapeutics Inc.

Biopharmaceuticals / Healthcare SOUTH SAN FRANCISCO, Calif. ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$197.0M
Funding Rounds
2
Last Funding
2025-02-12

About Aligos Therapeutics Inc.

ALIGOS Therapeutics is a biopharmaceutical company focused on improving patient outcomes through the development of best-in-class therapies for liver and viral diseases. Their mission is to address large unmet medical needs in these areas with purpose-built drugs that have enhanced pharmacologic properties.

Products & Services

ALG-000184:An oral small molecule capsid assembly modulator (CAM-E) under development for chronic hepatitis B virus infection.
ALG-055009:An oral small molecule thyroid hormone receptor beta (THR-β) agonist under development for metabolic dysfunction-associated steatohepatitis (MASH).

Specialties

Liver Diseases Viral Diseases Hepatology Virology Medicinal Chemistry Biology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement
A: 105000000
MR: -
FA: $105 million
FAN: 105000000
D: 2025-02-12
FD: 2025-02-12
2 investors
2 RT: Private Placement
T: -
FT: Private Placement
A: 92000000
MR: -
FA: $92 million
FAN: 92000000
D: 2023-10-23
FD: 2023-10-23
5 investors
Private Placement Latest
2025-02-12
$105.0M
2 investors (Pro only)
Private Placement 2023-10-23
$92.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

L

Lawrence M. Blatt

Chairman, President, & Chief Executive Officer

J

Julian A. Symons

Executive Vice President, Chief Scientific Officer

L

Lesley Ann Calhoun

Executive Vice President, Chief Operating Officer, and Chief Financial Officer

H

Hardean Achneck

Executive Vice President, Chief Medical Officer

S

Sushmita M. Chanda

Executive Vice President, Chief Development Officer

D

David B. Smith

Executive Vice President, Head of Chemical Operations

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Aligos Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
aligos.com
Industries
Biopharmaceuticals / Healthcare
Company Size
~300 employees (est.)
Locations
SOUTH SAN FRANCISCO, Calif.
South San Francisco, California
South San Francisco, Calif.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro